London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely. Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.
Med Chain aims to create a new trading lifestyle of C2M through the decentralization, non-tamperable and traceability of blockchain, combined with the actual situation of the e-commerce industry, reducing the transaction cost of consumers and improving the production efficiency of manufacturers. Globalized peer-to-peer trading is integrated into every aspect of life, and everyone can trade and everything can be traded. Peer-to-peer trading lifestyle: Med Chain expects to popularize C2M trading models into people's daily lives through blockchain technology, open up trust barriers between consumers and manufacturers, reduce trust costs, and achieve peer-to-peer customized e-commerce transactions. Global e-commerce bottom-level public chain: Med Chain expects to use POS and DPOS consensus mechanism to establish a global e-commerce transaction public chain, establish a transaction credit system based on blockchain technology, product copyright traceability system, intelligent payment system, and transaction after-sales arbitration system. The open data system is open to global developers, allowing blockchain technology to serve all walks of life in e-commerce.